Novel Vitreous Modulators for Pharmacologic Vitreolysis in the Treatment of Diabetic Retinopathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|3|410-422

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.3, 2011-01, pp. : 410-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic Vitreolysis in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 406-409

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic therapy for diabetic retinopathy

By Speicher Matthew A   Danis Ronald P   Criswell Mark   Pratt Linda  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite

Type IV Collagen Serum and Vitreous Fluid Levels in Patients with Diabetic Retinopathy

By Kotajima N   Kanda T   Yuuki N   Kimura T   Kishi S   Fukumura Y   Tamura J   Kobayashi I  

The Journal of International Medical Research, Vol. 29, Iss. 4, 2001-07 ,pp. : 292-296

Field House Publishing

Access to resources Recommend Favorite

Fibrates and Statins in the Treatment of Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 396-405

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Pharmacologic Approaches to the Prevention and Treatment of Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite